At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 6 enrolled
Drug / intervention
ECMO +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Awake Extracorporeal Membrane Oxygenation (ECMO) for Acute Respiratory Failure A Non-controlled, Single-center, Investigator-initiated Prove-of-concept Study
In Brief
A Phase 2 clinical trial evaluating ECMO and ECMO in non-intubated patients for ARDS. Completed, enrolled 6 participants across 1 site.
Detailed Summary
Proof-of-concept study addressing the feasibility of awake ECMO (v/v) in patients with acute respiratory failure
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsARDS
CountriesGermany
Collaborators--
Timeline
Phase 2CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2012
First PostedAug 2012
Primary CompletionApr 2013
TodayJul 2026
First PostedAug 21, 2012
Enrollment StartAug 1, 2012
Primary CompletionApr 1, 2013
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 13.9 years ago
Interventions
ECMOdevice
Use of veno-venous ECMO in non-intubated patients with ARDS
ECMO in non-intubated patientsprocedure
Use of veno-venous ECMO in non-intubated patients with ARDS